# AST-120 in Hemodialysis Patients With Uremic Pruritus

> **NCT04639674** · PHASE4 · COMPLETED · sponsor: **Conmed Pharmaceutical & Bio-Medical Corporation** · enrollment: 100 (actual)

## Conditions studied

- Uremic Pruritus

## Interventions

- **DRUG:** AST-120

## Key facts

- **NCT ID:** NCT04639674
- **Lead sponsor:** Conmed Pharmaceutical & Bio-Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-02
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-08-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04639674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04639674, "AST-120 in Hemodialysis Patients With Uremic Pruritus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04639674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*